Epidemiology: COPD in China – Aging, population growth, and increased survival will drive up prevalent cases over the next decade

Published by: Datamonitor

Published: Oct. 2, 2012 - 25 Pages

Table of Contents

Executive Summary

Epidemiologic results summary

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSOTIC CRITERIA

Spirometry is the gold standard for defining COPD

Cl

Abstract

Introduction

Datamonitor's research shows that out to 2010, COPD will continue to be a major threat to Chinese adults. The number of prevalent cases of COPD will increase substantially between 2011 and 2021, increasing from approximately 42 million to nearly 56 million. This increase will be driven by demographic changes over the forecast period, including increased survival and a larger aged population.

Features and benefits

• Gain insight to market potential, including a robust 10-year epidemiology forecast of COPD prevalent cases in China.
• Understand the key epidemiologic risk factors associated with COPD in China.

Highlights

The strong association between age and COPD means that the prevalence of COPD in the future will be especially sensitive to the increased survival that will result as access to healthcare increases; even though the disease is irreversible, its progress can be significantly slowed by quitting smoking and seeking medical care.Fewer than half of the estimated 42.83 million prevalent cases in 2011 were in the population between the ages of 40 and 60 years (14.56 million), which indicates that chronic obstructive pulmonary disease (COPD) is truly a disease of the aged in China.Urbanization will play a major role in the increase in the number of prevalent cases of COPD between 2011 and 2021. The average annual growth rate in urban settings will be 16 times that of the rural population (6.7% versus 0.4%).

Your key questions answered

• What are the most robust epidemiological studies for COPD prevalence in China?
• How will the patient population change over the next decade in the China?
• How do changes in population structure or risk factors affect the number of COPD cases in China in the forecast period?

Get full details about this report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.